A Case of Postablation Pericardial Effusion

Overview

Journal J Innov Card Rhythm Manag

Date 2020 Jun 2

PMID 32477786

Citations 2

Authors

Jeffrey B Ziffra

Nicholas D Germano

Angela N Phillips

Brian Olshansky

Affiliations

Soon will be listed here.

Abstract

Complications of atrial fibrillation ablation include pericardial effusion, which tends to occur acutely. Large and hemodynamically important effusions are uncommon, but a small effusion may be present at the end of the procedure in up to 22% of ablations. We monitor for pericardial effusions routinely after ablation with intracardiac echocardiography. However, the follow-up of a small effusion present immediately after ablation remains uncertain, especially with the use of dabigatran or another novel oral anticoagulant. There are no current recommendations on the follow-up of small pericardial effusions after ablation. We present a case and ask a panel of experts for their opinions.

Citing Articles

Post-cardiac injury syndrome after a concealed accessory pathway ablation.

Tatlisu M, Konal O, Atici A, Baycan O, Yilmaz Y J Cardiol Cases. 2022; 25(6):351-353.

PMID: 35685254 PMC: 9168982. DOI: 10.1016/j.jccase.2021.12.007.

Managing Postablation Pericardial Effusion.

J Innov Card Rhythm Manag. 2020; 9(10):3369-3371.

PMID: 32479563 PMC: 7252746. DOI: 10.19102/icrm.2018.091001.

References

Calkins H, Kuck K, Cappato R, Brugada J, Camm A, Chen S . 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial.... Heart Rhythm. 2012; 9(4):632-696.e21. DOI: 10.1016/j.hrthm.2011.12.016. View

Gianni C, Di Biase L, Mohanty S, Trivedi C, Bai R, Al-Ahmad A . Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series. J Cardiovasc Electrophysiol. 2016; 27(4):399-403. DOI: 10.1111/jce.12918. View

Deftereos S, Giannopoulos G, Efremidis M, Kossyvakis C, Katsivas A, Panagopoulou V . Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm. 2014; 11(4):620-8. DOI: 10.1016/j.hrthm.2014.02.002. View

Lellouche N, Sebag F, Elbaz N, Hassine M, Chaachoui N, Teiger E . Acute pericardial effusion following atrial fibrillation ablation: characteristics and relationship with arrhythmia recurrences. Arch Cardiovasc Dis. 2011; 104(8-9):450-7. DOI: 10.1016/j.acvd.2011.05.005. View

Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F . Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?. J Am Coll Cardiol. 2011; 57(2):160-6. DOI: 10.1016/j.jacc.2010.05.061. View

Lakkireddy D, Reddy Y, Di Biase L, Vallakati A, Mansour M, Santangeli P . Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol. 2014; 63(10):982-8. DOI: 10.1016/j.jacc.2013.11.039. View

Cappato R, Calkins H, Chen S, Davies W, Iesaka Y, Kalman J . Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2009; 53(19):1798-803. DOI: 10.1016/j.jacc.2009.02.022. View

Cappato R, Calkins H, Chen S, Davies W, Iesaka Y, Kalman J . Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005; 111(9):1100-5. DOI: 10.1161/01.CIR.0000157153.30978.67. View

Cooper J, Epstein L . Use of intracardiac echocardiography to guide ablation of atrial fibrillation. Circulation. 2001; 104(25):3010-3. DOI: 10.1161/hc5001.101503. View

10.

Schaer B, Maurer A, Sticherling C, Buser P, Osswald S . Routine echocardiography after radiofrequency ablation: to flog a dead horse?. Europace. 2008; 11(2):155-7. DOI: 10.1093/europace/eun360. View

11.

Ukaigwe A, Shrestha P, Karmacharya P, Hussain S, Samii S, Gonzalez M . Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation. J Interv Card Electrophysiol. 2016; 48(2):223-233. DOI: 10.1007/s10840-016-0195-5. View

12.

Imazio M, Brucato A, Ferrazzi P, Rovere M, Gandino A, Cemin R . Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011; 124(21):2290-5. DOI: 10.1161/CIRCULATIONAHA.111.026153. View

13.

Yukumi S, Ichiki H, Funada J, Suzuki H, Morimoto M, Fujita T . Postcardiac injury syndrome following vascular interventional radiofrequency ablation for paroxysmal atrial fibrillation. Respir Med Case Rep. 2015; 15:89-91. PMC: 4501502. DOI: 10.1016/j.rmcr.2015.03.008. View

14.

Garg J, Chaudhary R, Krishnamoorthy P, Palaniswamy C, Shah N, Bozorgnia B . Safety and efficacy of oral factor-Xa inhibitors versus Vitamin K antagonist in patients with non-valvular atrial fibrillation: Meta-analysis of phase II and III randomized controlled trials. Int J Cardiol. 2016; 218:235-239. DOI: 10.1016/j.ijcard.2016.05.059. View

15.

Kitamura T, Fukamizu S, Sakurada H, Hiraoka M . Development of delayed cardiac tamponade 55 days after catheter ablation for atrial fibrillation with a new oral anticoagulant. J Interv Card Electrophysiol. 2014; 41(2):135. DOI: 10.1007/s10840-014-9926-7. View

16.

Dillier R, Ammar S, Hessling G, Kaess B, Pavaci H, Buiatti A . Safety of continuous periprocedural rivaroxaban for patients undergoing left atrial catheter ablation procedures. Circ Arrhythm Electrophysiol. 2014; 7(4):576-82. DOI: 10.1161/CIRCEP.114.001586. View

17.

Chierchia G, Capulzini L, Droogmans S, Sorgente A, Sarkozy A, Muller-Burri A . Pericardial effusion in atrial fibrillation ablation: a comparison between cryoballoon and radiofrequency pulmonary vein isolation. Europace. 2010; 12(3):337-41. DOI: 10.1093/europace/eup422. View

18.

Garg J, Chaudhary R, Krishnamoorthy P, Shah N, Bozorgnia B, Natale A . Safety And Efficacy Of Uninterrupted Periprocedural Apixaban In Patients Undergoing Atrial Fibrillation Catheter Ablation: A Metaanalysis Of 1,057 Patients. J Atr Fibrillation. 2016; 8(6):1368. PMC: 5089471. DOI: 10.4022/jafib.1368. View